Short answer
MapLight Therapeutics, Inc. (MPLT) filed an 8-K current report with the SEC on April 29, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Two directors, Robert Malenka and Jim Trenkle, will not seek reelection at the June 23, 2026 annual meeting.
MapLight Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Two directors, Robert Malenka and Jim Trenkle, will not seek reelection at the June 23, 2026 annual meeting
- Martin Babler and Troy Cox nominated as Class I replacements
- Departures unrelated to disagreements over operations, policies or practices
- Board composition changes pending shareholder approval at the annual meeting
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MapLight Therapeutics, Inc. 8-K filings
Get the next MPLT 8-K as it lands
Follow MPLT for push alerts, or ask the research agent what this filing means.